Rhumbline Advisers Has $15.95 Million Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Posted by Defense World Staff on Sep 1st, 2023

Rhumbline Advisers cut its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 1.4% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 271,582 shares of the company’s stock after selling 3,813 shares during the period. Rhumbline Advisers owned 0.32% of HealthEquity worth $15,945,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in HQY. PNC Financial Services Group Inc. increased its stake in shares of HealthEquity by 31.8% in the 1st quarter. PNC Financial Services Group Inc. now owns 13,547 shares of the company’s stock valued at $913,000 after acquiring an additional 3,266 shares during the last quarter. AlphaCrest Capital Management LLC bought a new stake in shares of HealthEquity in the 1st quarter valued at about $234,000. Natixis Advisors L.P. bought a new stake in shares of HealthEquity in the 1st quarter valued at about $932,000. Bank of Montreal Can increased its stake in shares of HealthEquity by 44.5% in the 1st quarter. Bank of Montreal Can now owns 8,218 shares of the company’s stock valued at $553,000 after acquiring an additional 2,532 shares during the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in shares of HealthEquity by 10.7% in the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 30,639 shares of the company’s stock valued at $2,066,000 after acquiring an additional 2,952 shares during the last quarter. 98.46% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Trading Down 0.8 %

NASDAQ:HQY opened at $67.55 on Friday. HealthEquity, Inc. has a twelve month low of $48.86 and a twelve month high of $79.20. The company has a quick ratio of 4.00, a current ratio of 4.00 and a debt-to-equity ratio of 0.45. The business has a 50 day moving average price of $65.32 and a two-hundred day moving average price of $61.33. The company has a market cap of $5.77 billion, a P/E ratio of -675.50, a price-to-earnings-growth ratio of 2.59 and a beta of 0.82.

HealthEquity (NASDAQ:HQY – Get Free Report) last released its quarterly earnings results on Monday, June 5th. The company reported $0.32 earnings per share for the quarter, topping analysts’ consensus estimates of $0.23 by $0.09. HealthEquity had a positive return on equity of 4.30% and a negative net margin of 0.93%. The firm had revenue of $244.43 million during the quarter, compared to the consensus estimate of $239.85 million. As a group, analysts expect that HealthEquity, Inc. will post 1.2 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. StockNews.com assumed coverage on HealthEquity in a research note on Thursday, August 17th. They issued a “hold” rating for the company. Deutsche Bank Aktiengesellschaft increased their target price on HealthEquity from $69.00 to $71.00 in a research note on Wednesday, June 7th. Three investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $82.33.

Check Out Our Latest Analysis on HealthEquity

Insiders Place Their Bets

In other news, CEO Jon Kessler sold 19,588 shares of the stock in a transaction that occurred on Monday, June 26th. The stock was sold at an average price of $60.12, for a total value of $1,177,630.56. Following the completion of the sale, the chief executive officer now owns 6,129 shares of the company’s stock, valued at approximately $368,475.48. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other news, CEO Jon Kessler sold 19,588 shares of the stock in a transaction that occurred on Monday, June 26th. The stock was sold at an average price of $60.12, for a total value of $1,177,630.56. Following the completion of the sale, the chief executive officer now owns 6,129 shares of the company’s stock, valued at approximately $368,475.48. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Elimelech Rosner sold 10,156 shares of the stock in a transaction that occurred on Monday, June 12th. The shares were sold at an average price of $64.29, for a total value of $652,929.24. Following the completion of the sale, the executive vice president now directly owns 70,334 shares of the company’s stock, valued at approximately $4,521,772.86. The disclosure for this sale can be found here. Insiders own 2.70% of the company’s stock.

About HealthEquity

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.